Patients with BC who had decreased miR‐92a‐3p expression also had higher rates of advanced stage/grade and ER expression, whereas decreased miR‐1245b‐5p expression was only linked to ER expression and was not associated with lymph node metastasis. Here, ESR1 is linked to breast cancer.